down arrow

Medinova Diagno.

  • Market Cap: Micro Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE047C01019
  • NSEID:
  • BSEID: 526301
INR
38.89
0.09 (0.23%)
BSENSE

Apr 11, 12:47 PM

BSE+NSE Vol: 2.86 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.86 k (-57.01%) Volume

Shareholding (Mar 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

62.14%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 4.44% and Operating profit at 0% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

Risky - Negative Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 39 Cr (Micro Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.14

stock-summary
Return on Equity

-87.27%

stock-summary
Price to Book

-17.60

Revenue and Profits (1 Year):
Net Sales:
2 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-1.54%
0%
-1.54%
1 Year
14.18%
0%
14.18%
2 Years
77.01%
0%
77.01%
3 Years
5.54%
0%
5.54%
4 Years
63.4%
0%
63.4%
5 Years
162.06%
0%
162.06%

Medinova Diagno. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.44%
EBIT Growth (5y)
28.91%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
2.16
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-111.60%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
55
Price to Book Value
-17.60
EV to EBIT
15.00
EV to EBITDA
14.27
EV to Capital Employed
41.24
EV to Sales
4.21
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
270.00%
ROE (Latest)
Negative BV
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Vijaya Diagnostic Centre Limited (62.14%)

Highest Public shareholder

Shankar Lal Saraf (3.27%)

Individual Investors Holdings

35.97%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -12.11% vs 2.81% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -24.00% vs 19.05% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.25",
          "val2": "2.56",
          "chgp": "-12.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.66",
          "val2": "0.80",
          "chgp": "-17.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.13",
          "val2": "0.13",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.38",
          "val2": "0.50",
          "chgp": "-24.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.33%",
          "val2": "31.25%",
          "chgp": "-1.92%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -4.54% vs 5.38% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -8.00% vs 51.52% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.05",
          "val2": "5.29",
          "chgp": "-4.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.50",
          "val2": "1.44",
          "chgp": "4.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.25",
          "val2": "0.29",
          "chgp": "-13.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.92",
          "val2": "1.00",
          "chgp": "-8.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.70%",
          "val2": "27.22%",
          "chgp": "2.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -4.95% vs 6.08% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -7.14% vs 57.30% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.30",
          "val2": "7.68",
          "chgp": "-4.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.16",
          "val2": "2.04",
          "chgp": "5.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.38",
          "val2": "0.43",
          "chgp": "-11.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.30",
          "val2": "1.40",
          "chgp": "-7.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.59%",
          "val2": "26.56%",
          "chgp": "3.03%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 1.80% vs -24.32% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 19.76% vs -26.43% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.17",
          "val2": "9.99",
          "chgp": "1.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.79",
          "val2": "2.60",
          "chgp": "7.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.57",
          "val2": "0.60",
          "chgp": "-5.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.00",
          "val2": "1.67",
          "chgp": "19.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.43%",
          "val2": "26.03%",
          "chgp": "1.40%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
2.25
2.56
-12.11%
Operating Profit (PBDIT) excl Other Income
0.66
0.80
-17.50%
Interest
0.13
0.13
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.38
0.50
-24.00%
Operating Profit Margin (Excl OI)
29.33%
31.25%
-1.92%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -12.11% vs 2.81% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -24.00% vs 19.05% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
5.05
5.29
-4.54%
Operating Profit (PBDIT) excl Other Income
1.50
1.44
4.17%
Interest
0.25
0.29
-13.79%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.92
1.00
-8.00%
Operating Profit Margin (Excl OI)
29.70%
27.22%
2.48%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -4.54% vs 5.38% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -8.00% vs 51.52% in Sep 2023

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
7.30
7.68
-4.95%
Operating Profit (PBDIT) excl Other Income
2.16
2.04
5.88%
Interest
0.38
0.43
-11.63%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.30
1.40
-7.14%
Operating Profit Margin (Excl OI)
29.59%
26.56%
3.03%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -4.95% vs 6.08% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -7.14% vs 57.30% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
10.17
9.99
1.80%
Operating Profit (PBDIT) excl Other Income
2.79
2.60
7.31%
Interest
0.57
0.60
-5.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.00
1.67
19.76%
Operating Profit Margin (Excl OI)
27.43%
26.03%
1.40%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 1.80% vs -24.32% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 19.76% vs -26.43% in Mar 2023

stock-summaryCompany CV
About Medinova Diagnostic Services Ltd stock-summary
stock-summary
Medinova Diagnostic Services Ltd
Micro Cap
Hospital & Healthcare Services
Medinova Diagnostic Services Ltd (MDSL), incorporated in Mar.'93, commenced business on 26 Mar.'93. It belongs to Standard Organics group. The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology.
Company Coordinates stock-summary
Company Details
HNo 7-1-58/A/FF/8 Unit No 8, Amrutha Business Cplx Ameerpet Hyderabad Telangana : 500016
stock-summary
Tel:
stock-summary
medicorp@medinovaindia.com
Registrar Details
XL Softech Systems Ltd , 3 Sagar Society Road , No 2 Banjara Hills, Hyderabad